These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 9746723)

  • 1. Human endothelial cell migration is stimulated by urokinase plasminogen activator:plasminogen activator inhibitor 1 complex released from endometrial stromal cells stimulated with transforming growth factor beta1; possible mechanism for paracrine stimulation of endometrial angiogenesis.
    Sandberg T; Casslén B; Gustavsson B; Benraad TJ
    Biol Reprod; 1998 Oct; 59(4):759-67. PubMed ID: 9746723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paracrine stimulation of capillary endothelial cell migration by endometrial tissue involves epidermal growth factor and is mediated via up-regulation of the urokinase plasminogen activator receptor.
    Sandberg T; Ehinger A; Casslén B
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1724-30. PubMed ID: 11297609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor beta1 in the human endometrium. Cyclic variation, increased expression by estradiol and progesterone, and regulation of plasminogen activators and plasminogen activator inhibitor-1.
    Casslén B; Sandberg T; Gustavsson B; Willén R; Nilbert M
    Biol Reprod; 1998 Jun; 58(6):1343-50. PubMed ID: 9623591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of epidermal growth factor and transforming growth factor beta-1 on the release of fibrinolytic factors from cultured endometrial and ovarian endometriotic stromal cells.
    Guan YM; Carlberg M; Bruse C; Bergqvist A
    Gynecol Obstet Invest; 2003; 55(1):7-13. PubMed ID: 12624545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological mechanisms underlying the clinical effects of RU 486: modulation of cultured endometrial stromal cell plasminogen activator and plasminogen activator inhibitor expression.
    Lockwood CJ; Krikun G; Papp C; Aigner S; Schatz F
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1100-5. PubMed ID: 7714076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of hormones on uPA, PAI-1 and suPAR from cultured endometrial and ovarian endometriotic stromal cells.
    Guan YM; Carlberg M; Bruse C; Carlström K; Bergqvist A
    Acta Obstet Gynecol Scand; 2002 May; 81(5):389-97. PubMed ID: 12027810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. uPA and MMP-2 were involved in self-assembled network formation in a two dimensional co-culture model of bone marrow stromal cells and endothelial cells.
    Li H; Daculsi R; Bareille R; Bourget C; Amedee J
    J Cell Biochem; 2013 Mar; 114(3):650-7. PubMed ID: 23059760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal release of urokinase plasminogen activator, plasminogen activator inhibitor-1, and soluble plasminogen activator receptor from separated and cultured endometriotic and endometrial stromal and epithelial cells.
    Bruse C; Guan Y; Carlberg M; Carlström K; Bergqvist A
    Fertil Steril; 2005 Apr; 83 Suppl 1():1155-60. PubMed ID: 15831288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of thrombin on steroid-modulated cultured endometrial stromal cell fibrinolytic potential.
    Lockwood CJ; Krikun G; Aigner S; Schatz F
    J Clin Endocrinol Metab; 1996 Jan; 81(1):107-12. PubMed ID: 8550736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degradation of urokinase plasminogen activator (UPA) in endometrial stromal cells requires both the UPA receptor and the low-density lipoprotein receptor-related protein/alpha2-macroglobulin receptor.
    Casslén B; Gustavsson B; Angelin B; Gåfvels M
    Mol Hum Reprod; 1998 Jun; 4(6):585-93. PubMed ID: 9665342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the urokinase receptor in vascular endothelial cells is stimulated by basic fibroblast growth factor.
    Mignatti P; Mazzieri R; Rifkin DB
    J Cell Biol; 1991 Jun; 113(5):1193-201. PubMed ID: 1645739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen activators augment endothelial cell organization in vitro by two distinct pathways.
    Schnaper HW; Barnathan ES; Mazar A; Maheshwari S; Ellis S; Cortez SL; Baricos WH; Kleinman HK
    J Cell Physiol; 1995 Oct; 165(1):107-18. PubMed ID: 7559792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of plasminogen activator in rat endometrial stromal cells: the role of prostaglandin E2.
    Zhang X; Shu MA; Ross HE; Kennedy TG
    Biol Reprod; 1996 May; 54(5):1046-51. PubMed ID: 8722625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential localization and expression of urokinase plasminogen activator (uPA), its receptor (uPAR), and its inhibitor (PAI-1) mRNA and protein in endometrial tissue during the menstrual cycle.
    Nordengren J; Pilka R; Noskova V; Ehinger A; Domanski H; Andersson C; Høyer-Hansen G; Hansson SR; Casslén B
    Mol Hum Reprod; 2004 Sep; 10(9):655-63. PubMed ID: 15243126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High urokinase expression contributes to the angiogenic properties of endothelial cells derived from circulating progenitors.
    Basire A; Sabatier F; Ravet S; Lamy E; Mialhe A; Zabouo G; Paul P; Gurewich V; Sampol J; Dignat-George F
    Thromb Haemost; 2006 Apr; 95(4):678-88. PubMed ID: 16601839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombospondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast cancer cells.
    Arnoletti JP; Albo D; Granick MS; Solomon MP; Castiglioni A; Rothman VL; Tuszynski GP
    Cancer; 1995 Sep; 76(6):998-1005. PubMed ID: 8625226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasminogen activator inhibitor type-1 mutants regulate angiogenesis of human umbilical and lung vascular endothelial cells.
    Chorostowska-Wynimko J; Swiercz R; Skrzypczak-Jankun E; Selman SH; Jankun J
    Oncol Rep; 2004 Dec; 12(6):1155-62. PubMed ID: 15547731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of urokinase-type plasminogen activator in sphingosylphosphorylcholine-induced angiogenesis.
    Piao YJ; Lee CH; Zhu MJ; Kye KC; Kim JM; Seo YJ; Suhr KB; Park JK; Kim CD; Lee JH
    Exp Dermatol; 2005 May; 14(5):356-62. PubMed ID: 15854129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of plasminogen activator inhibitor 1 expression by interaction of epidermal growth factor with progestin during decidualization of human endometrial stromal cells.
    Lockwood CJ
    Am J Obstet Gynecol; 2001 Apr; 184(5):798-804; discussion 804-5. PubMed ID: 11303186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation and role of urokinase plasminogen activator in vascular remodelling.
    Tkachuk V; Stepanova V; Little PJ; Bobik A
    Clin Exp Pharmacol Physiol; 1996 Sep; 23(9):759-65. PubMed ID: 8911711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.